GILEAD SCIENCES EXEC SAYS EXPECTING FDA DECISION ON HIV TREATMENT LENACAPVIR IN LATE DECEMBER : CONF CALL
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
67.72 USD | -0.21% | +2.67% | 84.36B | ||
- Stock Market
- Stock Market News in real time
- Economy
- Gilead Sciences Exec Says Expecting Fda Decision On Hiv Treatmen…